$87.8
Revenue is up for the last 2 quarters, 50.48B → 53.45B (in $), with an average increase of 5.6% per quarter
Netprofit is down for the last 2 quarters, 347.0M → -64.0M (in $), with an average decrease of 118.4% per quarter
In the last 1 year, Mckesson Corporation has given 27.4% return, outperforming this stock by 0.3%
In the last 3 years, Mckesson Corporation has given 196.1% return, outperforming this stock by 110.9%
0.17%
Downside
Day's Volatility :0.87%
Upside
0.7%
26.14%
Downside
52 Weeks Volatility :32.06%
Upside
8.01%
Period | Cardinal Health, Inc. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -6.15% | -1.1% | -2.3% |
6 Months | 21.48% | 1.6% | 7.6% |
1 Year | 27.06% | 4.2% | 14.9% |
3 Years | 85.15% | 24.2% | 27.5% |
Market Capitalization | 22.2B |
Book Value | - $11.36 |
Dividend Share | 1.988 |
Dividend Yield | 2.24% |
Earnings Per Share (EPS) | 1.0 |
PE Ratio | 88.67 |
PEG Ratio | 0.65 |
Wall Street Target Price | 98.08 |
Profit Margin | 0.13% |
Operating Margin TTM | 0.86% |
Return On Assets TTM | 2.53% |
Return On Equity TTM | 0.0% |
Revenue TTM | 205.0B |
Revenue Per Share TTM | 785.49 |
Quarterly Revenue Growth YOY | 13.5% |
Gross Profit TTM | 6.5B |
EBITDA | 2.5B |
Diluted Eps TTM | 1.0 |
Quarterly Earnings Growth YOY | -0.57 |
EPS Estimate Current Year | 5.74 |
EPS Estimate Next Year | 6.59 |
EPS Estimate Current Quarter | 1.49 |
EPS Estimate Next Quarter | 1.44 |
What analysts predicted
Upside of 11.71%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 136.8B | ↑ 5.26% |
Net Income | 256.0M | ↓ 80.12% |
Net Profit Margin | 0.19% | ↓ 0.8% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 145.5B | ↑ 6.38% |
Net Income | 1.4B | ↑ 432.42% |
Net Profit Margin | 0.94% | ↑ 0.75% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 152.9B | ↑ 5.08% |
Net Income | -3.7B | ↓ 371.17% |
Net Profit Margin | -2.42% | ↓ 3.36% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 162.5B | ↑ 6.24% |
Net Income | 611.0M | ↓ 116.53% |
Net Profit Margin | 0.38% | ↑ 2.8% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 181.4B | ↑ 11.63% |
Net Income | -933.0M | ↓ 252.7% |
Net Profit Margin | -0.51% | ↓ 0.89% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 205.0B | ↑ 13.04% |
Net Income | 261.0M | ↓ 127.97% |
Net Profit Margin | 0.13% | ↑ 0.64% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 44.8B | ↓ 1.37% |
Net Income | -1.4B | ↓ 2938.78% |
Net Profit Margin | -3.1% | ↓ 3.21% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 47.1B | ↑ 5.06% |
Net Income | 138.0M | ↓ 109.92% |
Net Profit Margin | 0.29% | ↑ 3.39% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 49.6B | ↑ 5.31% |
Net Income | 110.0M | ↓ 20.29% |
Net Profit Margin | 0.22% | ↓ 0.07% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 51.5B | ↑ 3.76% |
Net Income | -130.0M | ↓ 218.18% |
Net Profit Margin | -0.25% | ↓ 0.47% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 50.5B | ↓ 1.91% |
Net Income | 347.0M | ↓ 366.92% |
Net Profit Margin | 0.69% | ↑ 0.94% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 53.5B | ↑ 5.87% |
Net Income | -64.0M | ↓ 118.44% |
Net Profit Margin | -0.12% | ↓ 0.81% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 40.0B | ↓ 0.4% |
Total Liabilities | 33.9B | ↑ 1.83% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 41.0B | ↑ 2.53% |
Total Liabilities | 34.6B | ↑ 2.19% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 40.8B | ↓ 0.48% |
Total Liabilities | 39.0B | ↑ 12.53% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 44.5B | ↑ 9.04% |
Total Liabilities | 42.7B | ↑ 9.46% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 43.9B | ↓ 1.29% |
Total Liabilities | 44.6B | ↑ 4.51% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 43.4B | ↓ 1.05% |
Total Liabilities | 46.3B | ↑ 3.78% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 42.1B | ↓ 3.59% |
Total Liabilities | 42.8B | ↑ 0.3% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 43.9B | ↑ 4.2% |
Total Liabilities | 44.6B | ↑ 4.16% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 43.4B | ↓ 1.12% |
Total Liabilities | 45.2B | ↑ 1.31% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 44.5B | ↑ 2.52% |
Total Liabilities | 46.7B | ↑ 3.38% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 43.4B | ↓ 2.48% |
Total Liabilities | 45.6B | ↓ 2.35% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 43.4B | ↑ 0.09% |
Total Liabilities | 46.3B | ↑ 1.47% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.8B | ↑ 133.78% |
Investing Cash Flow | -5.6B | ↑ 1284.69% |
Financing Cash Flow | -2.3B | ↓ 160.76% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.7B | ↓ 1.66% |
Investing Cash Flow | 338.0M | ↓ 106.03% |
Financing Cash Flow | -2.3B | ↑ 0.75% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.0B | ↓ 27.99% |
Investing Cash Flow | 493.0M | ↑ 45.86% |
Financing Cash Flow | -2.2B | ↓ 4.06% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.4B | ↑ 23.93% |
Investing Cash Flow | -378.0M | ↓ 176.67% |
Financing Cash Flow | -1.3B | ↓ 40.14% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.1B | ↑ 28.53% |
Investing Cash Flow | 567.0M | ↓ 250.0% |
Financing Cash Flow | -2.5B | ↑ 87.02% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.8B | ↓ 9.06% |
Investing Cash Flow | -454.0M | ↓ 180.07% |
Financing Cash Flow | -3.1B | ↑ 23.87% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -419.0M | ↓ 135.06% |
Investing Cash Flow | -44.0M | ↓ 6.38% |
Financing Cash Flow | -340.0M | ↓ 23.42% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.0B | ↓ 814.08% |
Investing Cash Flow | -204.0M | ↑ 363.64% |
Financing Cash Flow | -415.0M | ↑ 22.06% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 23.0M | ↓ 99.23% |
Investing Cash Flow | -70.0M | ↓ 65.69% |
Financing Cash Flow | -1.2B | ↑ 180.24% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 597.0M | ↑ 2495.65% |
Investing Cash Flow | -87.0M | ↑ 24.29% |
Financing Cash Flow | -362.0M | ↓ 68.87% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.4B | ↑ 127.97% |
Investing Cash Flow | -91.0M | ↑ 4.6% |
Financing Cash Flow | -934.0M | ↑ 158.01% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 858.0M | ↓ 36.96% |
Investing Cash Flow | -206.0M | ↑ 126.37% |
Financing Cash Flow | -592.0M | ↓ 36.62% |
Sell
Neutral
Buy
Cardinal Health, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Cardinal Health, Inc. | -1.89% | 21.48% | 27.06% | 85.15% | 63.04% |
![]() Cencora Inc | 3.5% | 3.5% | 3.5% | 54.87% | 66.6% |
![]() Mckesson Corporation | 4.96% | 25.36% | 27.35% | 196.08% | 235.0% |
![]() Henry Schein, Inc. | -6.06% | -8.02% | 9.46% | 22.82% | 9.84% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Cardinal Health, Inc. | 88.67 | 88.67 | 0.65 | 5.74 | 0.0 | 0.03 | 0.02 | -11.36 |
![]() Cencora Inc | 21.28 | 21.28 | 1.58 | 11.93 | 2.34 | 0.03 | 0.01 | 3.39 |
![]() Mckesson Corporation | 16.53 | 16.53 | 0.62 | 25.95 | 0.0 | 0.04 | 0.01 | -11.87 |
![]() Henry Schein, Inc. | 21.54 | 21.54 | 1.94 | 5.27 | 0.1 | 0.06 | 0.0 | 27.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Cardinal Health, Inc. | Hold | $22.2B | 63.04% | 88.67 | 0.13% |
![]() Cencora Inc | NA | $35.1B | 66.6% | 21.28 | 0.66% |
![]() Mckesson Corporation | Buy | $59.8B | 235.0% | 16.53 | 1.32% |
![]() Henry Schein, Inc. | Hold | $9.7B | 9.84% | 21.54 | 3.64% |
Vanguard Group Inc
BlackRock Inc
State Street Corporation
FMR Inc
Geode Capital Management, LLC
Arrowstreet Capital Limited Partnership
In the quarter ending March,2023. Cardinal Health, Inc. has declared dividend of $0.5
Read Morecardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.
Organization | Cardinal Health, Inc. |
Employees | 47040 |
CEO | Mr. Jason M. Hollar |
Industry | Wholesale Trade |
Realty Income Corporation
$87.80
-0.27%
Caterpillar Inc.
$87.80
-0.27%
Sun Communities Inc
$87.80
-0.27%
Liberty Media Group - Class A
$87.80
-0.27%
Fresenius Medical Care Ag & Co. Kgaa
$87.80
-0.27%
Weyerhaeuser Co.
$87.80
-0.27%
Global Payments Inc.
$87.80
-0.27%
Martin Marietta Materials, Inc.
$87.80
-0.27%
Nextera Energy, Inc.
$87.80
-0.27%